CNMD  Conmed Corporation




Health Care


Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.


Vuru Grade


Current Price

+1.01 (+2.52%)

Growth Price

Fairly valued

Stability Price

Overvalued by 54.02%

Company Metrics

  • 32.04 P/E
  • 1.46 P/S
  • 1.82 P/B
  • 1.249 EPS
  • 5.79% Cash ROIC
  • 0.49 Cash Ratio
  • 0.8 / 2% Dividend
  • 206,237.00 Avg. Vol.
  • 1.122B Market Cap.

Company Description

CONMED Corporation, a medical technology company, provides surgical devices and equipment for minimally invasive procedures and monitoring. The company's products serve the clinical areas of arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring disposables, endosurgery, and endoscopic technologies. It offers arthroscopy products, including powered resection instruments, art...

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


CONMED Corporation Announces Third Quarter 2014 Financial Results
MarketWatch - Oct 23, 2014
CONMED is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures.
CONMED Corporation to Announce Third Quarter 2014 Financial Results on ...
MarketWatch - Oct 8, 2014
UTICA, NY, Oct 08, 2014 (Marketwired via COMTEX) -- CONMED Corporation CNMD, +1.37% announced today that it will report third quarter 2014 financial results at 4:00 PM Eastern time on Thursday, October 23, 2014, and will also hold a conference call at ...
CONMED Q3 Earnings Rise but Revenues Fall - 18 hours ago
CONMED Corporation (CNMD - Analyst Report) posted adjusted earnings per share of 44 cents for the third quarter of 2014, up 10% from 40 cents recorded in the same quarter of 2013.
ConMed profit, sales fall in third quarter - The Central New York Business Journal
CONMED Co. (CNMD) Updates FY14 Earnings Guidance - WKRB News
CONMED (CNMD) Announces Quarterly Results
WKRB News - Oct 23, 2014
CONMED logo CONMED (NASDAQ:CNMD) issued its quarterly earnings data on Thursday. The company reported $0.44 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.39 by $0.05, Analyst RN reports.
CONMED Co. (CNMD) Releases FY14 Earnings Guidance
Watch List News (press release) - Oct 23, 2014
CONMED logo CONMED Co. (NASDAQ:CNMD) issued an update on its FY14 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $1.85-1.95 for the period, compared to the Thomson Reuters consensus ...
CONMED Q3 Profit Tops Estimate; Backs FY14 View
Nasdaq - Oct 24, 2014
Based on the third quarter results, the company affirmed its full year 2014 revenue guidance of $735 million to $745 million and adjusted earnings per share guidance of $1.85 to $1.95.
CONMED (CNMD) Scheduled to Post Quarterly Earnings on Thursday
Watch List News (press release) - Oct 21, 2014
CONMED logo CONMED (NASDAQ:CNMD) is scheduled to issue its quarterly earnings data on Thursday, October 23rd. CONMED has set its FY14 guidance at $1.85-1.95 EPS.Persons that wish to listen to the company's earnings conference call can do so ...
Conmed Q3 14 Earnings Conference Call At 4:30 PM ET
Nasdaq - Oct 23, 2014
( - Conmed Corp.( CNMD ) will host a conference call at 4:30 PM ET on October 23, 2014, to discuss its Q3 14 earnings results.
Biggest Movers in Healthcare Stocks Now - EW IDXX RMD SPNC - 19 hours ago
Conmed Corp (CNMD): CNMD stock is up 2.9% today. Newlink Genetics Corp (NLNK): NLNK stock is up 1.4% today and up 114.3% in the last month.
Trending Tickers: Amgen Inc. (NASDAQ:AMGN), The Dow Chemical Company ...
Equities Focus (registration) - Oct 3, 2014
On September 12, ConMed Corp. (NASDAQ:CNMD), a Utica–based surgical-device maker, announced that shareholders have elected all eight of its director nominees.